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Abstract 21 
Pseudomonas aeruginosa is a versatile opportunistic pathogen capable of infecting a broad range of 22 
hosts, in addition to thriving in a broad range of environmental conditions outside of hosts. With this 23 
versatility comes the need to tightly regulate its genome to optimise its gene expression and behaviour 24 
to the prevailing conditions. Two-component systems (TCSs) comprising sensor kinases and response 25 
regulators, play a major role in this regulation. This minireview discusses the growing number of two-26 
component systems that have been implicated in the virulence of Pseudomonas aeruginosa, with a 27 
special focus on the emerging theme of multikinase networks, which are networks comprising 28 
multiple sensor kinases working together, sensing and integrating multiple signals to decide upon the 29 
best response. The networks covered in depth regulate processes such as the switch between acute and 30 
chronic virulence (GacS network), the Cup fimbriae (Roc network and Rcs/Pvr network), the 31 
aminoarabinose modification of lipopolysaccharide (a network involving the PhoQP and PmrBA 32 
TCSs), twitching motility and virulence (a network formed from the Chp chemosensory pathway and 33 
the FimS/AlgR TCS), and biofilm formation (Wsp chemosensory pathway). In addition, we highlight 34 




Pseudomonas aeruginosa has a remarkably diverse ability to thrive in many different environments 39 
both outside and within a host. To be successful in these diverse situations, P. aeruginosa needs to 40 
sense its environment, decide upon an appropriate response and modify its behaviour accordingly to 41 
better suit prevailing conditions. Regulatory networks are key to this decision-making process. P. 42 
aeruginosa has a large genome (6.3 Mb for the reference PAO1 strain), reflecting the diverse range of 43 
environments and hosts that it can inhabit, and just under 10 % of its genes are dedicated to these 44 
regulatory networks (Stover et al. 2000). Two-component systems (TCSs) comprising sensor kinases 45 
(SKs) and response regulators (RRs) (Stock et al. 2000), play a major role in these regulatory 46 
networks with P. aeruginosa having 64 SKs, 72 RRs and 3 Hpt proteins (Rodrigue et al. 2000; Stover 47 
et al. 2000).  48 
As an opportunist pathogen, being capable of both acute and chronic infection, P. aeruginosa has a 49 
multitude of virulence factors and antibiotic resistance determinants (Driscoll et al. 2007; Gooderham 50 
& Hancock 2009; Coggan & Wolfgang 2012). Well over 50 % of the TCSs of P. aeruginosa have 51 
been linked to virulence, controlling either virulence related behaviour or contributing towards in vivo 52 
fitness and colonisation ability. This number has grown considerably in recent years, primarily due to 53 
the successful application of whole-genome based methodologies for identifying genes involved in 54 
virulence, such as Tn-Seq approaches using animal infection models, and the study of pathoadaptive 55 
mutations in isolates from cystic fibrosis (CF) patients (Table 1). 56 
TCSs are generally considered to work alone, sensing either a single stimulus or a narrow range of 57 
stimuli to control appropriate responses, being insulated from significant crosstalk (Laub & Goulian 58 
2007; Capra et al. 2012), with relatively few exceptions (Willett & Crosson 2017). However, a 59 
recently emerging theme, in which tremendous progress has been made in the last few years, is the 60 
discovery that multikinase networks play leading roles in orchestrating the virulence of P. aeruginosa. 61 
Multikinase-networks comprise multiple SKs that collaborate to form sophisticated networks capable 62 
of sensing and integrating multiple stimuli. In the following sections, we explore how these networks 63 
regulate virulence.   64 
The transition between acute and chronic modes of infection: the GacS network 65 
The GacS network plays a leading role in governing the transition between acute and chronic modes 66 
of infection. It has emerged as a prime example of a multikinase network, where multiple SKs work 67 
together to detect and integrate several different signals to reach a balanced decision. The central 68 
kinase in this network, GacS, controls the phosphorylation of the RR, GacA (Figure 1). 69 
Phosphorylated GacA activates the transcription of two non-coding RNAs, RsmY and RsmZ, and 70 
they bind and sequester the translational regulators, RsmA (Brencic et al. 2009) and the more recently 71 
discovered RsmN (Morris et al. 2013). Free RsmA and RsmN bind to certain mRNAs, promoting the 72 
degradation of transcripts involved in chronic virulence (e.g. relating to biofilm formation, T6SS, and 73 
extracellular products like pyocyanin and cyanide) while favouring those involved in acute infection 74 
(e.g. relating to T3SS and motility) (Reimmann et al. 1997a; Parkins et al. 2001; Pessi et al. 2001; 75 
Valverde et al. 2003; Heurlier et al. 2004; Burrowes et al. 2006; Mulcahy et al. 2008b; Brencic & 76 
Lory 2009; Moscoso et al. 2011; Morris et al. 2013). In short, when GacS signalling is active, GacA 77 
will be phosphorylated and this will favour the chronic mode of infection.  78 
GacS is an unorthodox kinase (containing HisKA, HATPase, REC and Hpt domains) whose 79 
signalling activity is controlled through kinase-kinase interactions by three hybrid SKs, RetS, LadS 80 
and PA1611. RetS and LadS interact with GacS, with RetS inhibiting, and LadS activating, GacS 81 
signalling (Goodman et al. 2004; Laskowski et al. 2004; Laskowski & Kazmierczak 2006; Ventre et 82 
al. 2006). RetS downregulates GacS signalling by binding to GacS and reducing its ability to 83 
autophosphorylate (Goodman et al. 2009), whereas LadS upregulates GacS signalling through a 84 
phosphorelay mechanism where phosphoryl groups are transferred from the REC domain of LadS to 85 
the Hpt domain of GacS (Chambonnier et al. 2016). Unlike RetS and LadS, PA1611 does not interact 86 
with GacS; instead, PA1611 binds to RetS, which prevents it from inhibiting GacS (Kong et al. 2013; 87 
Bhagirath et al. 2017). The interaction of the four SKs allows for the integration of signals to 88 
modulate GacS phosphorylation levels and therefore, the output of the pathway. The signals that 89 
activate the various SKs are largely unidentified. However, GacS and RetS are controlled by 90 
molecules produced at high cell density and during the lysis of kin cells, respectively, although the 91 
identity of these molecules remains elusive (Heeb et al. 2002; LeRoux et al. 2015). Recently, it has 92 
been shown that LadS from P. aeruginosa is activated by calcium ions to upregulate chronic 93 
phenotypes (Broder et al. 2016). 94 
The importance of the GacS network has been demonstrated using infection models, with Tn-Seq 95 
studies finding that most components of the network are required in either acute and/or chronic 96 
virulence in mice (Turner et al. 2014). Moreover, isolates from CF patients often have pathoadaptive 97 
mutations within GacS network components, indicating that fine-tuning the signalling of the network 98 
can facilitate long-term colonisation and bacterial survival (Cramer et al. 2011; Marvig et al. 2015). 99 
Interestingly, strain PA14, which was originally isolated from a burn wound, has a frameshift 100 
mutation in ladS. Relative to many other strains, PA14 shows enhanced acute virulence, which can, in 101 
part, be attributed to the mutation in ladS (Mikkelsen et al. 2011). Another clinical isolate, CHA, has 102 
a deletion in gacS and exhibits enhanced acute virulence phenotypes (Sall et al. 2014). These studies 103 
show the importance of this network in infection and how environmental pressures can reshape the 104 
virulence of P. aeruginosa by mutationally fine-tuning this network.  105 
The HptB branch of the GacS network. Two of the SKs that form part of the core of the GacS 106 
network, RetS and PA1611 (described above), also interact with HptB and together form the HptB 107 
branch of the GacS network along with two further hybrid SKs, SagS and ErcS’ (Lin et al. 2006; Hsu 108 
et al. 2008). HptB is a histidine phosphotransfer protein (Hpt) that serves in a phosphorelay 109 
connecting, RetS, PA1611, SagS and ErcS’ with an unusual output RR, HsbR (PA3346).  HsbR has 110 
an N-terminal REC domain, a protein phosphatase 2C (PP2C)-like domain, and a C-terminal ser/thr 111 
kinase domain (Hsu et al. 2008; Bhuwan et al. 2012). When phosphorylated, HsbR acts as a 112 
phosphatase to dephosphorylate the anti-anti sigma factor, HsbA (PA3347). Dephosphorylated HsbA 113 
(red arrow on Figure 1) then sequesters the anti-sigma factor FlgM, which is otherwise found in a 114 
complex with the sigma factor, FliA. Free FliA promotes expression of the flagellar genes and 115 
therefore both swimming and swarming motility (Bhuwan et al. 2012). 116 
When HptB is inactive (i.e. not phosphorylated or absent), the receiver domain of HsbR 117 
dephosphorylates, which causes the ser/thr kinase domain of HsbR to be more active than its 118 
phosphatase domain. Consequently, HsbR phosphorylates HsbA, preventing it from binding and 119 
sequestering FlgM. FlgM instead binds FliA and this leads to a decreased expression of the flagellar 120 
genes. Furthermore, phosphorylated HsbA (blue arrow on Figure 1) is thought to bind to, and activate, 121 
the diguanylate cyclase HsbD, which leads to an increase in c-di-GMP and RsmY levels (Bordi et al. 122 
2010; Valentini et al. 2016). How exactly HsbD modulates RsmY levels is not known, but it is known 123 
that the upregulation of rsmY expression in the ΔhptB mutant depends upon intact GacS/GacA 124 
signalling (Bordi et al. 2010; Jean-Pierre et al. 2017).  125 
The SagS/BfiS branch of the GacS network. SagS is involved in the motile-sessile switch and 126 
resistance to antimicrobials (Petrova & Sauer 2011; Petrova et al. 2017), and as well as being one of 127 
the SKs that can phosphorylate HptB (Petrova & Sauer 2011), SagS has a HptB independent 128 
signalling route. SagS regulates both RsmY and RsmZ through distinct pathways; its regulation of 129 
RsmY is HptB dependent (Bordi et al. 2010; Petrova & Sauer 2011), while its regulation of RsmZ is 130 
HptB independent and involves an interaction with another SK, BfiS. BfiS is required for the 131 
transition to irreversible attachment of cells during biofilm formation. The interaction between SagS 132 
and BfiS relies upon the conserved phosphorylation sites of these SKs (Petrova & Sauer 2010, 2011).  133 
The cognate RR of BfiS, BfiR, activates expression of CafA (RNase G). CafA reduces the level of 134 
RsmZ, which is required for maturation and maintenance of biofilms (Petrova & Sauer 2010). The 135 
SagS/BfiS branch of the network, therefore regulates the level of RsmZ post-transcriptionally, while 136 
the rest of the GacS network regulates both RsmY and RsmZ at the transcriptional level (Ventre et al. 137 
2006; Goodman et al. 2009). RsmY and RsmZ levels can also be influenced by other regulators such 138 
as Anr/NarL, which downregulates both sRNAs under conditions of low oxygen, and the -lactamase 139 
regulator, AmpR, which can upregulate RsmZ (O’Callaghan et al. 2011; Balasubramanian et al. 140 
2015). It appears that levels of these sRNAs are tightly coordinated by multiple intersecting regulators 141 
to orchestrate the transition from acute to chronic virulence and the planktonic to biofilm mode of 142 
growth.  143 
The GacS network produces and responds to c-di-GMP. Two major ways that the GacS network is 144 
known to affect c-di-GMP levels are firstly, that RsmA controls the translation of the sadC mRNA, 145 
which encodes the diguanylate cyclase, SadC (Moscoso et al. 2014), and secondly, the HptB branch 146 
of the GacS network regulates the HsbD diguanylate cyclase (Valentini et al. 2016). Intriguingly, in 147 
addition to controlling c-di-GMP levels, the GacS network appears to respond to c-di-GMP levels. 148 
Overexpressing diguanylate cyclases can induce the T3SS (acute) to T6SS (chronic) switch, and this 149 
is dependent upon the regulatory RNAs, RsmY and RsmZ (Moscoso et al. 2011). RsmY and RsmZ 150 
levels have also been shown to be elevated in strains overexpressing diguanylate cyclases (Frangipani 151 
et al. 2014).  It is therefore tempting to speculate that increased c-di-GMP levels activate signalling 152 
within the GacS network to help promote biofilm formation and the chronic mode of virulence. In line 153 
with this, it has recently been shown that the PilZ-domain-protein, HapZ, can bind to SagS and inhibit 154 
phosphotransfer to HptB, in a c-di-GMP dependent manner (Xu et al. 2016). In addition, it is possible 155 
that c-di-GMP affects signalling elsewhere in the network in yet to be determined ways.  156 
In summary, the GacS network is a complex multikinase-network that plays a major role in deciding 157 
between acute and chronic modes of virulence, and between planktonic and biofilm modes of growth. 158 
The complexity of the network and the large number of different sensors is likely to reflect the 159 
importance of making the correct decision to the survival of the bacterium, and the need to evaluate 160 
numerous signals (e.g. Ca2+, kin-cell lysis, c-di-GMP plus several other as yet unidentified signals) in 161 
order to inform this decision. 162 
Control of Cup fimbriae production: The Roc network and Rcs/Pvr network 163 
Surface adhesins, known as Cup fimbriae (chaperone/usher pili), are required for the initial 164 
attachment stage of biofilm formation. P. aeruginosa has three different sets of archetypal Cup 165 
fimbriae genes in its core genome (cupA, cupB and cupC). The PA14 strain has an extra set of 166 
fimbriae genes, cupD, within the PAPI-I pathogenicity island. The cupB and cupC genes are 167 
controlled by the Roc network, while the cupD genes of PA14 are regulated by the Rcs/Pvr network 168 
(Kulasekara et al. 2005; Rao et al. 2008; Mikkelsen et al. 2009; Mikkelsen et al. 2013). In addition to 169 
regulating the CupB and CupC fimbriae, the Roc network also controls expression of the MexAB-170 
OprM drug efflux pump (Sivaneson et al. 2011). 171 
Like the GacS network, the Roc network is another good example of a multikinase network, and again 172 
c-di-GMP signalling is involved, but unlike the GacS network, which is built from kinase-kinase 173 
interactions, the Roc network is instead based upon SKs sharing the same RRs (Figure 2A). This 174 
network comprises two SKs, RocS1 and RocS2, which are both unorthodox (having HisKA, 175 
HATPase, REC and Hpt domains), that control at least three RRs, RocA1 (helix-turn-helix DNA 176 
binding output domain), RocR (EAL, c-di-GMP degrading, phosphodiesterase output domain) and 177 
RocA2 (helix-turn-helix DNA binding output domain). Each of the two SKs is capable of interacting 178 
with each of the RRs. The RRs target different genes; RocA1 activates expression of the CupC 179 
fimbriae, RocA2 inhibits expression of the MexAB-OprM drug efflux pump, while RocR by reducing 180 
c-di-GMP levels, reduces expression of both cupB and cupC fimbriae genes. There is good reason to 181 
believe that an additional RR is involved in this network as the two SKs, RocS1 and RocS2, promote 182 
expression of CupB fimbriae genes in a manner independent of any of the three known RRs 183 
(Kulasekara et al. 2005; Rao et al. 2008; Sivaneson et al. 2011). Although the controlling stimuli are 184 
unknown for the Roc network, the cross-regulation within this network should allow multiple inputs 185 
to be evaluated and for these signals to be integrated. 186 
Roc network signalling promotes adhesion and therefore biofilm formation, while reducing 187 
expression of the MexAB-OprM antibiotic efflux pump. Initially, this seems counterintuitive, as 188 
biofilms are usually associated with increased antibiotic resistance. However, reduced expression of 189 
mexAB-oprM is seen in mature biofilms, and strains isolated from CF patients often show inactivation 190 
of this efflux pump despite having a high propensity for biofilm formation (De Kievit et al. 2001; 191 
Vettoretti et al. 2009). This suggests that the MexAB-OprB drug efflux pump is not involved in the 192 
antibiotic resistance of biofilms.  193 
The cupD cluster, found in strain PA14, is regulated by an orthologous system to the Roc network 194 
consisting of two SKs, RcsC (unorthodox) and PvrS (hybrid) and two RRs, RcsB and PvrR (Figure 195 
2B). Like the Roc system, RcsB has a HTH DNA-binding domain, while PvrR has an EAL output 196 
domain. Interestingly, in this system, PvrS appears to act as a kinase, while RcsC functions primarily 197 
as a phosphatase and also acts in an intermolecular phosphorelay connecting PvrS with the output 198 
RRs. In this phosphorelay, phosphoryl groups are passed from the REC domain of the hybrid SK, 199 
PvrS, to the Hpt domain of RcsC and from there onto the REC domains of the output RRs. This 200 
kinase-kinase phosphorelay mode of interaction is reminiscent of the GacS/LadS interaction in the 201 
GacS network and is likely to represent a conserved signalling route where the Hpt domain of an 202 
unorthodox kinase is used to connect hybrid kinases (that lack Hpt domains) with their output RRs  203 
(Mikkelsen et al. 2009; Mikkelsen et al. 2013; Chambonnier et al. 2016).     204 
The regulatory network controlling the aminoarabinose modification of lipopolysaccharide  205 
During infection, P. aeruginosa needs to evade host defences such as cationic antimicrobial peptides, 206 
and to resist any antibiotic treatments that the patient may be receiving. One major way that this can 207 
be achieved is by inducing the aminoarabinose modification of the lipid A component of the 208 
lipopolysaccharide layer. This modification reduces the negative charge on the LPS, thereby limiting 209 
its electrostatic interaction with, and the subsequent uptake of, cationic antimicrobial peptides and 210 
cationic lipopeptide antibiotics (including polymyxins such as colistin, which are often used as last-211 
resort antibiotics in CF patients). The genes required for the modification are encoded by the 212 
arnBCADTEF operon and it is regulated by a sensory network comprising at least five distinct two-213 
component systems each comprising a SK and a RR; PhoQP, PmrBA, ColSR, CprSR and ParSA 214 
(Macfarlane et al. 1999; Macfarlane et al. 2000; McPhee et al. 2003; Moskowitz et al. 2004; 215 
Gooderham et al. 2009; Gooderham & Hancock 2009; Fernández et al. 2010; Fernández et al. 2012; 216 
Gutu et al. 2013; Lee & Ko 2014).   217 
Unlike the GacS and Roc networks, there is no documented linkage at the phosphosignalling level 218 
between these TCSs, instead the output RRs of the separate TCSs converge upon the aminoarabinose 219 
modification genes (Figure 3), as a common feature of each RR’s unique wider regulon. The SKs, 220 
PhoQ and PmrB, are active when the Mg2+ concentration is low (McPhee et al. 2006), while the SKs, 221 
CprS and ParS are activated by different cationic antimicrobial peptides (Fernández et al. 2010; 222 
Muller et al. 2011; Fernández et al. 2012), and ColS is activated by Zn2+ (Nowicki et al. 2015). 223 
Extracellular DNA is a significant component of the biofilm matrix and is often found at infection 224 
sites, and it appears to play an important physiological role in the PhoQP and PmrBA responses, as it 225 
sequesters cations and can reduce Mg2+ levels to the extent that PhoQ and PmrB signalling are 226 
activated, thereby promoting LPS modification and increasing resistance to host cationic peptides and 227 
polymyxins (Mulcahy et al. 2008a; Gellatly et al. 2012; Lewenza 2013).  228 
This regulatory network undergoes strong selective pressures in CF patients and adaptive mutations 229 
are frequently identified in isolates from CF patients, particularly those who have been treated with 230 
polymyxins. These mutations can be in any of the TCSs of this network although mutations affecting 231 
PhoQP and PmrBA are particularly common; generally, they lead to either increased or constitutive 232 
expression of the genes for the aminoarabinose modification, and are frequently accompanied by 233 
other mutations in non-TCS genes (such as those for LPS biogenesis and outer membrane protein 234 
assembly) that further boost resistance levels (Barrow & Kwon 2009; Fernández et al. 2010; Miller et 235 
al. 2011; Gellatly et al. 2012; Moskowitz et al. 2012; Gutu et al. 2013; Jochumsen et al. 2016). 236 
Surface sensing: The Wsp chemosensory pathway 237 
One way that P. aeruginosa responds to growth on surfaces is by activating the Wsp chemosensory 238 
system. This pathway controls the production of the secondary messenger, c-di-GMP, which promotes 239 
biofilm formation and decreases expression of the flagellar genes. Like the Chp chemosensory system 240 
(below), the Wsp chemosensory system forms a signal transduction system (Figure 4) resembling the 241 
bacterial chemotaxis system (He & Bauer 2014). The Wsp pathway incorporates the cytoplasmic SK, 242 
WspE, which phosphorylates two RRs, the methylesterase, WspF, and the diguanylate cyclase, WspR 243 
(Bantinaki et al. 2007). Surface growth is sensed by the membrane bound WspA protein (a methyl-244 
accepting-chemotaxis protein homologue), possibly via mechanical sensing of physical pressure 245 
resulting from surface association and cell-cell contact (O’Connor et al. 2012). Contact sensing by 246 
WspA triggers autophosphorylation of WspE, which in turn phosphorylates and activates WspR and 247 
WspF. WspR-P catalyses the production of c-di-GMP through its GGDEF domain (Bantinaki et al. 248 
2007; De et al. 2008; De et al. 2009). When WspR is dephosphorylated, it is delocalised within the 249 
cytoplasm, but when phosphorylated, it aggregates to form cytoplasmic clusters (Guvener & Harwood 250 
2007), where its diguanylate cyclase activity is increased (Huangyutitham et al. 2013). WspF-P acts to 251 
reset the system by removing methyl groups from WspA (Hickman et al. 2005; Bantinaki et al. 2007). 252 
Deletion of wspF results in constitutive activation of WspR (WspR-P) due to overmethylation of 253 
WspA and produces a distinctive wrinkled, small colony phenotype with enhanced biofilm formation 254 
(Hickman et al. 2005).  255 
Activation of the Wsp pathway by surface sensing triggers an increase in c-di-GMP levels (Hickman 256 
et al. 2005; O’Connor et al. 2012; Ha & O'Toole 2015). The transcriptional regulator, FleQ, is the 257 
major target for the c-di-GMP produced by the Wsp pathway. FleQ promotes expression of the 258 
flagellar genes and downregulates biofilm associated genes (e.g. pel encoding exopolysaccharide 259 
biosynthesis proteins). FleQ is inhibited by binding c-di-GMP, and therefore Wsp pathway activation 260 
leads to reduced expression of the flagellar genes and increased expression of biofilm associated 261 
genes (Hickman et al. 2005; Hickman & Harwood 2008).  262 
Consistent with its role in promoting biofilm formation, Tn-Seq data has shown that the Wsp pathway 263 
is required for chronic wound infections in mice (Turner et al. 2014). Moreover, isolates from CF 264 
patients often show pathoadaptive mutations in the Wsp pathway (Marvig et al. 2015); wspF 265 
mutations being particularly common with their distinctive phenotype of having a rugose appearance 266 
and enhanced biofilm formation (D'Argenio et al. 2002; Hickman et al. 2005; Smith et al. 2006; 267 
Starkey et al. 2009; Sousa & Pereira 2014; Blanka et al. 2015). This indicates that the Wsp pathway is 268 
under selective pressures to affect its signalling output during long-term infection, with constitutive 269 
activation being favourable for biofilm growth and chronic infection.  270 
Surface sensing: The Chp/FimS/AlgR network 271 
The Wsp pathway and the Chp/FimS/AlgR network are distinct but have many similarities; both sense 272 
surface contact, both involve a chemosensory pathway, both use secondary messenger signalling, and, 273 
like many other signalling networks, both contribute to biofilm formation. In that sense they can be 274 
considered to form a super network (O'Toole & Wong 2016). The Chp/FimS/AlgR network is itself 275 
an example of a multikinase network. It regulates production of two different secondary messengers, 276 
cAMP and c-di-GMP to control virulence and biofilm formation (Figure 5). The production and 277 
activity of type 4 pili (T4P) are also controlled by this network and, moreover, they play a central 278 
signalling role. T4P are major surface adhesins allowing adherence and invasion of host tissues (Hahn 279 
1997).  They are located at the cell poles and undergo repeated cycles of extension, adhesion and 280 
retraction to pull the cell forward in a process called twitching motility (Skerker & Berg 2001; 281 
Mattick 2002). The extension and retraction of these pili are controlled by the Chp chemosensory 282 
pathway part of the Chp/FimS/AlgR network, which also controls levels of the secondary messenger, 283 
cyclic AMP (cAMP) (Darzins 1994; Whitchurch et al. 2004; Fulcher et al. 2010). cAMP regulates 284 
many other cellular processes and genes, primarily via the transcription factor Vfr (Virulence factor 285 
regulator) which upregulates many virulence genes, including those involved with quorum sensing, 286 
type 2 secretion, T3SS, the FimS/AlgR TCS and the T4P themselves (Albus et al. 1997; Wolfgang et 287 
al. 2003; Kanack et al. 2006; Bertrand et al. 2010; Fulcher et al. 2010).  288 
The Chp chemosensory pathway resembles, but is distinct from, the chemotaxis pathway regulating 289 
flagellar rotation. It uses a methyl-accepting-chemotaxis-protein (MCP) homologue, PilJ, to detect 290 
surface contact and chemoattractants such as phosphatidylethanolamine (Kearns et al. 2001; Jansari et 291 
al. 2016). Sensing of surface contact involves mechanosensing, where PilJ is thought to respond to 292 
tension generated within the pili, when the cell retracts pili that have adhered to surfaces  (Persat et al. 293 
2015). The signal from PilJ is relayed via two adaptor proteins, PilI and ChpC to an unorthodox SK, 294 
ChpA. ChpA is one of the most complex SKs found in any bacterial species, having nine potential 295 
phosphorylation sites; it has eight ‘Xpt’ domains, six of which are conventional Hpt domains and two 296 
that contain either serine or threonine in place of the usual phosphorylatable histidine, plus a receiver 297 
domain (ChpArec) (Whitchurch et al. 2004; Leech & Mattick 2006). ChpA autophosphorylates on 298 
Hpt domains 4-6 and phosphotransfer occurs from Hpts 5 and 6 to ChpArec, but also, at a slower rate, 299 
to two standalone RRs; PilG and PilH. Reversible phosphotransfer can occur from ChpArec to Hpt 2-300 
6, however, as yet, no phosphorylation has been observed on Hpt 1 or the remaining two ‘Xpt’ 301 
domains (Silversmith et al. 2016). Hpt 2 and Hpt 3 serve as the main phosphodonors to the two output 302 
RRs, PilG and PilH (Hpt5 and 6 also contribute but at a much slower rate), that control the adenylate 303 
cyclase, CyaB (Wolfgang et al. 2003; Fulcher et al. 2010; Silversmith et al. 2016), and the pilus 304 
extension (PilB) and retraction (PilT/U) ATPases (Bertrand et al. 2010). 305 
The RR, PilG, localises to the cell poles along with the pili forming a complex with FimL and FimV; 306 
presumably this helps to keep its local concentration high, proximal to its kinase, ChpA (Inclan et al. 307 
2016). The details of how PilG and PilH regulate adenylate cyclase and the pilus ATPases are not 308 
known, although models have been proposed based on genetic studies, where PilG stimulates pilus 309 
extension (via PilB) and CyaB activity, as the pilG mutant has reduced piliation and reduced cAMP 310 
levels, while PilH stimulates pilus retraction (via PilT/U) and inhibits CyaB activity, as the pilF 311 
mutant has increased piliation and increased cAMP  (Bertrand et al. 2010; Fulcher et al. 2010). The 312 
role of PilH is controversial though, and instead it might function as a phosphate sink for PilG rather 313 
than directly regulating CyaB and PilT/U. 314 
The Chp chemosensory pathway associates with the FimS/AlgR TCS (also known as AlgZ/R) to form 315 
the Chp/FimS/AlgR multikinase network. This network is constructed differently from the other 316 
examples of multikinase network discussed; here, the two SKs, FimS and ChpA do not interact 317 
directly but instead they interact with a common partner, the MCP homologue, PilJ. FimS is thought 318 
to be activated by surface contact, and an attractive model would be for the surface contact sensor, 319 
PilJ, to control FimS activity via their interaction (Luo et al. 2015). The FimS/AlgR TCS is best 320 
known for its role in controlling the production of the exopolysaccharide, alginate, but it is also 321 
required for twitching motility as it regulates expression of the T4P, and is involved in multiple other 322 
pathways including hydrogen cyanide and rhamnolipid production, T3SS, the Rhl quorum-sensing 323 
system, and biofilm formation (Whitchurch et al. 1996; Okkotsu et al. 2014).  324 
The role of cAMP as the initial secondary messenger in the Chp/FimS/AlgR network is well known, 325 
with the Chp chemosensory system producing cAMP in response to surface contact, which activates 326 
Vfr, leading to activation of the expression of many virulence genes including the FimS/AlgR TCS. 327 
However, recently, c-di-GMP has been implicated as a delayed secondary messenger from this 328 
network (Figure 5) i.e. following activation by surface contact, cAMP is produced initially and then 329 
several hours later c-di-GMP is produced, correlating with the onset of biofilm formation (O'Toole & 330 
Wong 2016). Two diguanylate cyclases are involved, SadC (which is also controlled by the GacS 331 
network) and MucR, with one of the targets for the c-di-GMP that they produce being the c-di-GMP 332 
binding protein, Alg44, which stimulates alginate production (Hay et al. 2009; Schmidt et al. 2016). 333 
MucR expression is stimulated by AlgR when the network senses surface contact (Kong et al. 2015). 334 
Regulation of SadC is more complex; AlgR and Vfr together upregulate the fimU-pilVWXXY1Y2E 335 
operon, that is necessary for T4P biogenesis and function (Luo et al. 2015). PilY1, encoded by this 336 
operon, is a cell surface associated protein that promotes the activity of SadC and downregulates 337 
swarming motility (Kuchma et al. 2010). Crucially, PilY1 depends upon the T4P for export ensuring 338 
an ordered signalling cascade where pili are made first, before PilY1 is deployed and c-di-GMP 339 
production initiated (Luo et al. 2015).  340 
Conclusions 341 
TCSs play a major role in controlling P. aeruginosa virulence, with over 50 % of its TCSs implicated 342 
in controlling either virulence or virulence related behaviours such as biofilm formation and antibiotic 343 
resistance (Table 1). A major theme highlighted by the above examples is that during infection, P. 344 
aeruginosa makes extensive use of multikinase networks to detect and integrate multiple 345 
environmental signals, and to reach a balanced decision about the most appropriate response. There 346 
are a multitude of different architectures for these multikinase networks:  347 
1. Kinase-kinase interaction. Seen in the GacS network (Figure 1) and the Rcs/Pvr network 348 
(Figure 2B).  349 
2. Multiple SKs can share the same RR(s), as in the Roc network (Figure 2A) and in the HptB 350 
branch of the GacS network (Figure 1). 351 
3. Connector proteins can link the SKs e.g. in the Chp/FimS/AlgR network, the surface contact 352 
sensing MCP homologue, PilJ, interacts with two SKs, ChpA and FimS (Figure 5).  353 
4. Regulatory convergence between TCSs, where otherwise separate TCSs control the 354 
expression of the same genes, as seen in the network controlling LPS modification (Figure 3).  355 
5. Transcriptional control of one TCS by another TCS e.g. in the Chp/FimS/AlgR system, the 356 
expression of the FimS/AlgR TCS is induced by Vfr, which is activated by binding cAMP 357 
that is produced by CyaB due to signalling by the ChpA SK (Figure 5).  358 
A further finding is that these regulatory networks undergo considerable selective pressure within 359 
hosts, particularly during chronic infection and it is common to isolate mutant strains with 360 
pathoadaptive mutations in these networks e.g. showing enhanced biofilm formation, increased 361 
antibiotic resistance, or reduced motility (Marvig et al. 2013; Marvig et al. 2015; Jochumsen et al. 362 
2016; Winstanley et al. 2016). This shows that while the wild-type regulatory networks may be 363 
capable of efficiently orchestrating virulence across a broad range of conditions, there are 364 
circumstances where the networks can be genetically fine-tuned to optimise behaviour to better suit 365 
the prevailing conditions e.g. chronic infection in the CF lung, although this often comes at expense of 366 
the bacterium’s ability to thrive in other conditions e.g. at causing acute infections (Smith et al. 2006; 367 
Jeukens et al. 2014).  368 
Another key theme illustrated by the above examples is the interplay between multikinase networks 369 
and secondary messenger systems, with several of the networks discussed modulating levels of c-di-370 
GMP. This provides another level of signal integration and decision making as all of the signals from 371 
several, otherwise separate, networks can feed into these secondary messengers to control common 372 
outputs important for virulence such as biofilm formation and motility.  373 
Key priorities for the future advancement of our understanding of these multikinase-networks that 374 
could facilitate the development of new ways of targeting these networks and tackling infection are: 375 
1. The ligands controlling many of the TCSs discussed above remain unknown, and although 376 
some recent progress has been made in this area (e.g. Broder et al. 2016) we urgently need 377 
systematic high-throughput methods for ligand identification. 378 
2. Determining which kinases work together in multikinase-networks is a key priority. It is 379 
likely that many of the SKs in Table 1 will feature in yet to be discovered multikinase-380 
networks. A combination of biochemical, bioinformatic and genetic methods need to be 381 
employed for systematic screening for potential interactions. 382 
3. Revealing the complex interfaces with other regulatory mechanisms i.e. secondary messenger 383 
signalling and one-component regulators, which frequently form integral parts of multikinase-384 
networks.    385 
4. Understanding how multikinase-networks process and integrate signals to make decisions. 386 
This will require a concerted effort employing mathematical modelling alongside a detailed 387 
biochemical understanding of the regulators involved, how they respond to signal, and their 388 
interactions and expression patterns. 389 
  390 
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References PAO1 PA14 PAO1 PA14 
Multikinase networks           
*GacS network controlling the acute/chronic switch           




GacA–GacS system. Virulence, quorum-sensing-dependent 
regulation of exoproducts and virulence factors, biofilm formation, 
antibiotic resistance, swarming motility, iron metabolism and T3/T6 
secretion. 
 Y Y (Reimmann et al. 1997; Rahme et al. 
2000; Parkins et al. 2001; Heeb et al. 
2002; Goodman et al. 2004; Soscia 
et al. 2007; Brencic et al. 2009; 
Goodman et al. 2009; Frangipani et 
al. 2014)  
PA1611 PA14_43670 Unknown PA1611-HptB-HsbR phosphorelay. Acute/chronic infection cycle in 
conjunction with the GacS network and has been shown to directly 
interact with RetS.  
 Y Y (Lin et al. 2006; Hsu et al. 2008; 
Kong et al. 2013; Bhagirath et al. 
2017) 
PA2824 PA14_27550 SagS Unknown Regulates the motile-sessile switch in biofilm formation. Linked 
with the GacS and HptB networks and the SK BfiS.  
 Y (Hsu et al. 2008; Petrova & Sauer 
2010, 2011)  
PA4197 PA14_09680 PA4196 PA14_09690 BfiS-BfiR Unknown Biofilm formation/maintenance.       Y Y Y   (Petrova & Sauer 2009).  
PA3345 PA14_20800 PA3346 PA14_20780 HptB-HsbR Unknown HptB-mediated phosphorelay, swarming motility and biofilm 
formation.  
Y  Y Y (Hsu et al. 2008; Bhuwan et al. 
2012) 
PA3974 LadS Ca2+ Regulates virulence, biofilm formation, and T3 
secretion/cytotoxicity via GacS.  
 Y Y (Ventre et al. 2006; Chambonnier et 
al. 2016) 
PA4856 PA14_64230 RetS Kin cell lysate  Regulates virulence, biofilm formation, and T3/T6 
secretion/cytotoxicity via GacS.  
Y Y Y (Goodman et al. 2004; Laskowski et 
al. 2004; Moscoso et al. 2011; 
LeRoux et al. 2015) 
*Roc network controlling the fimbrial cup genes           
PA3044  PA14_24720 PA3045 PA14_24710 RocS2-
RocA2 
Unknown RocA2–RocS2 system. Regulation of fimbriae adhesins and 
antibiotic resistance.  
 Y Y Y (Kulasekara et al. 2005; Sivaneson et 
al. 2011)  









Unknown RocS1–RocR–RocA1 (SadA–SadR–SadS system). Biofilm 
maturation, fimbrial genes, T3 secretion and antibiotic resistance. 
RocA1 contains EAL output domain, RocR is a RocA1 antagonist. 
 Y (Gallagher & Manoil 2001; Kuchma 
et al. 2005; Kulasekara et al. 2005; 
Sivaneson et al. 2011)  
*RcsCB/PvrSR network controlling the cupD fimbrial genes           
 PA14_59800  PA14_59790 PvrS-PvrR Unknown Phenotypic variation, antibiotic resistance, biofilm formation. 
Controls cupD fimbriae genes. 
       (Drenkard & Ausubel 2002; 
Mikkelsen et al. 2009; Mikkelsen et 
al. 2013)  
 PA14_59780  PA14_59770 RcsC-RcsB Unknown Biofilm formation. Controls cupD fimbriae genes        (Mikkelsen et al. 2009; Mikkelsen et 
al. 2013) 














Regulates ethanol oxidation control and it is implicated in biofilm 
specific antibiotic resistance. PA14_38910 is essential.  
Y  Y Y Y Y (Mern et al. 2010; Beaudoin et al. 
2012)  
PA1992 PA14_38740 ErcS Possible 
cytosolic 
metabolites 
Regulates ethanol oxidation control and it is implicated in biofilm 
specific antibiotic resistance.  
 Y (Mern et al. 2010; Beaudoin et al. 
2012)  
  PA3604 PA14_17670 ErdR Unknown Ethanol oxidation control, implicated in biofilm specific antibiotic 
resistance.  
 Y (Mern et al. 2010; Beaudoin et al. 
2012)  
Network detecting phosphate limitation and tricarboxylic acids          
PA0757 PA14_54500 PA0756 PA14_54510 TctE-TctD Tricarboxylic 
acids 
Controls expression of tricarboxylic acid uptake system.     Y Y Y (Bielecki et al. 2015) 
PA5361 PA14_70760 PA5360 PA14_70750 PhoR–PhoB Inorganic 
phosphate 
Quorum sensing & swarming motility.     Y Y  (Blus-Kadosh et al. 2013; Faure et 
al. 2013; Bielecki et al. 2015) 
*Chp/FimS/AlgR network controlling twitching motility, virulence and biofilm formation         







PilH/       
ChpB 
Unknown Chemosensory pili (Pil–Chp) system, twitching motility and cAMP 
levels. Virulence genes. 
 Y Y (Darzins & Russell 1997; 
Whitchurch et al. 2004; Bertrand et 
al. 2010; Fulcher et al. 2010; Luo et 
al. 2015; Persat et al. 2015; Inclan et 
al. 2016; Silversmith et al. 2016) 
PA5262 PA14_69480 PA5261 PA14_69470 FimS(AlgZ)-
AlgR 
Unknown Virulence, alginate biosynthesis, twitching and swarming motility, 
biofilm formation, cyanide production, cytotoxicity and type III 
secretion system gene expression.  
 Y Y Y (Intile et al. 2014; Okkotsu et al. 
2014)  
*Network controlling the aminoarabinose modification of LPS           
PA1179 PA14_49170 PA1179 PA14_49180 PhoQ–PhoP Mg2+ Low Mg2+ signal. Polymyxin, antimicrobial peptide and 
aminoglycoside resistance. Virulence, swarming motility and 
biofilm formation. 
    Y Y  (Ernst et al. 1999; Macfarlane et al. 
1999; Macfarlane et al. 2000; 
Ramsey & Whiteley 2004; McPhee 
et al. 2006; Jochumsen et al. 2016). 
PA1798 PA14_41270 PA1799 PA14_41260 ParS-ParR Cationic peptides Multi-drug resistance, quorum sensing, phenazine production and 
swarming.  
     Y  (Fernández et al. 2010; Muller et al. 
2011; Wang et al. 2013).  
PA3078 PA14_24340 PA3077 PA14_24350 CprS-CprR Antimicrobial 
peptides 
Triggers LPS modification and adaptive antimicrobial peptide 
resistance.  
   Y    (Fernández et al. 2010).  
PA4380 PA14_56940 PA4381 PA14_56950 ColS-ColR Zn2+ Polymyxin resistance, mutants have decreased virulence in a C. 
elegans model and decreased cell adherence.  
    Y Y Y (Garvis et al. 2009; Gutu et al. 
2013).  
PA4777 PA14_63160 PA4776 PA14_63150 PmrB–PmrA Mg2+ Induced by low Mg2+ and cationic antimicrobial peptides. 
Polymyxin B, colistin and antimicrobial peptide resistance.  
 Y    Y Y (McPhee et al. 2003; Moskowitz et 
al. 2004; McPhee et al. 2006; Lee & 
Ko 2014).  
 
 
Other two-component systems implicated in virulence           
PA0033 PA14_00420 HptC   Unknown Histidine containing phosphotransfer protein   Y Y  
  PA0034 PA14_00430  Unknown PA0034 is repressed during in vitro growth in CF sputum medium. 
Located directly upstream of hptC (PA0033).  
 Y Y (Palmer et al. 2005)  
  PA0173 PA14_02180 CheB Unknown Y  Y Y  
PA0178 PA14_02250 PA0179 PA14_02260  Unknown  Y Y  
PA0991 PA14_51480 HptA  Unknown Histidine containing phosphotransfer protein   Y Y  
PA0464 PA14_06070 PA0463 PA14_06060 CreC–CreB Penicillin-
binding protein 4 
(PBP4) 
Catabolism. Swarming and swimming motility. Antibiotic 
resistance, biofilm and global gene regulation.  
 Y Y (Wagner et al. 2007; Zamorano et al. 
2014)  
PA0600 PA14_07820 PA0601 PA14_07840 AgtS-AgtR Peptidoglycan Involved in sensing peptidoglycan and controlling virulence.   Y Y Y (Korgaonkar et al. 2013).  
PA0930 PA14_52240 PA0929 PA14_52250 PirR–PirS Unknown Iron acquisition.  Y  Y Y Y (Vasil & Ochsner 1999)  
PA1098 PA14_50200 PA1099 PA14_50180 FleS–FleR Unknown Flagellar motility and adhesion to mucin. FleS likely cytoplasmic 
sensor.  
 Y Y (Ritchings et al. 1995; Dasgupta et 
al. 2003).  
PA1136 PA14_46980 PA1135 PA14_49710 Unknown Antibodies against PA1136 found in CF patient sera.   (Beckmann et al. 2005). 
PA1158 PA14_49420 PA1157 PA14_49440 Unknown Y  Y Y Y  
PA1243 PA14_48160 Unknown  Y Y  
PA1336 PA14_46980 PA1335 PA14_46990 AauS-AauR Unknown  Y  
PA1396 PA14_46370 PA1397 PA14_46360 DSF Unknown Interspecies signalling. Responds to diffusible signal factor (DSF) 
and regulates biofilm formation and antibiotic resistance. 
 Y (Ryan et al. 2008) 
PA1438 PA14_45870 PA1437 PA14_45880 Unknown  Y  
PA1456 PA14_45620 CheY Unknown  Y Y Y  
PA1458 PA14_45590 PA1459 PA14_45580 Unknown  Y Y  
PA1636 PA14_43350 PA1637 PA14_43340 KdpD-KdpE Unknown  Y Y  
  PA1785 PA14_41490 NasT Unknown  Y Y Y  
  PA2137 PA14_36920  Unknown  Y Y  
PA2177 PA14_36420    Unknown      Y Y Y   
PA2376 PA14_33920 Unknown  Y Y Y   
PA2480 PA14_32570 PA2479 PA14_32580 Unknown Essential in PA14  Y Y  
PA2524 PA14_31950 PA2523 PA14_31960  CzcS–CzcR Zinc, cadmium or 
cobalt 
Regulates metal resistance and antibiotic resistance and 
pathogenicity.  
 Y (Hassan et al. 1999; Dieppois et al. 
2012)  
PA2571 PA14_30840 PA2572 PA14_30830  Unknown Affects motility, virulence and antibiotic resistance. Works with 
PA2573 (an MCP homologue). 
 
 Y (McLaughlin et al. 2012) 
PA2583 PA14_30700  Unknown  Y  
PA2656 PA14_29740  PA2657 PA14_29730  BqsS-BqrR / 
(CarS-CarR) 
Extracellular 
Fe(II) and CaCl2 
Biofilm decay, Ferrous iron sensing, antibiotic resistance and 
cationic stress tolerance. Maintains Ca2+ homeostasis, regulates 
pyocyanin, swarming and tobramycin sensitivity. PA14_29740 is an 
essential gene 
 Y Y Y Y (Dong et al. 2008; Kreamer et al. 
2015; Guragain et al. 2016) 
PA2687 PA14_29360 PA2686 PfeS–PfeR Enterobactin Iron acquisition.   Y Y (Dean et al. 1996)  
PA2798 PA14_27940 Unknown Described as essential in PA14   Y Y Y  
PA2810 PA14_27800 PA2809 PA14_27810  CopS–CopR Copper Metal and imipenem resistance.   Y Y Y (Teitzel et al. 2006; Caille et al. 
2007)  
PA2882 PA14_26810 PA2881 PA14_26830  Unknown  Y Y  
  PA2899 PA14_26570  Unknown  Y  
PA3191 PA14_22960 PA3192 PA14_22940 GtrS-GltR 2-ketogluconate Glucose transport and type III secretion cytotoxicity.  Y  Y Y Y Y (Wolfgang et al. 2003; O'Callaghan 
et al. 2012; Daddaoua et al. 2014)  
PA3206 PA14_22730 PA3204 PA14_22760 CpxA-CpxR Unknown Antibodies against PA3206 found in CF patient sera.  Implicated in 
cell envelope stress response.  Activates MexAB-OprM efflux pump 
expression and enhances antibiotic resistance. 
 Y Y Y (Beckmann et al. 2005; Yakhnina et 
al. 2015; Tian et al. 2016) 
PA3271 PA14_21700 Unknown Y  Y  
PA3349 PA14_20750 Unknown  Y  
PA3462 PA14_19340 Unknown  Y  
PA3704 PA14_16470 PA3702 PA14_16500 WspE–WspR Surface 
associated growth 
Wsp chemosensory system. Regulates biofilm, autoaggregation and 
cyclic-di-GMP. WspR contains GGDEF output domain, WspE is 
CheA-type sensor.  
Y Y Y (D'Argenio et al. 2002; Hickman et 
al. 2005; Kulasekara et al. 2005; 
Borlee et al. 2010; Huangyutitham et 
al. 2013)  
PA3714 PA14_16350 Unknown  Y  
PA3878 PA14_13740 PA3879 PA14_13730 NarX–NarL Nitrate Nitrate sensing and respiration. Biofilm formation, fermentation, 
swimming and swarming motility.  
Y  Y (Van Alst et al. 2007; Benkert et al. 
2008)    PA4032 PA14_11680   Y  
PA4036 PA14_11630  Unknown  Y  
  PA4080 PA14_11120  Unknown  Y Y  
PA4102 PA4101 BfmS-BfmR Unknown Biofilm formation/maintenance.   Y Y Y (Petrova & Sauer 2009)  






PA4293 PA14_55780 PA4296 PA14_55810 PprA–PprB Unknown Outer-membrane permeability and aminoglycoside resistance. 
Virulence including T3 secretion and biofilm formation.  
Y  Y Y (Wang et al. 2003; Giraud et al. 
2011; de Bentzmann et al. 2012)  
PA4398 PA14_57170 PA4396 PA14_57140  Unknown Overexpression impairs T3 secretion-mediated cytotoxicity. 
GGDEF output domain. In PA14, PA4398 sensor kinase regulates 
motility and biofilm. PA14_57170 is essential in PA14. 
 Y Y (Kulasakara et al. 2006; Strehmel et 
al. 2015) 
PA4494 PA14_58320 PA4493 PA14_58300 RoxS-RoxR Possibly cyanide Cyanide tolerance. Neutrophil transmigration response.   Y Y Y (Comolli & Donohue 2002; Hurley 
et al. 2010; Fernández-Piñar et al. 
2012)  
PA4546 PA14_60250 PA4547 PA14_60260 PilS–PilR Pilin subunits Biofilm formation, type IV pilus expression, twitching and 
swarming motility.  
 Y Y Y Y (Ishimoto & Lory 1992; Hobbs et al. 
1993; Overhage et al. 2007; Kilmury 
& Burrows 2016) 
PA4725 PA14_62530 PA4726 PA14_62540 CbrA–CbrB Various carbon 
sources 
Carbon and nitrogen storage, cytotoxicity, swarming motility, 
modulates metabolism, virulence, and antibiotic resistance in PA14. 
 Y Y Y (Gallagher & Manoil 2001; Rietsch 
et al. 2004; Wagner et al. 2007; 
Yeung et al. 2011; Yeung et al. 
2014)    PA4781 PA14_63210  Unknown  Y  
PA4886 PA14_64580 PA4885 PA14_64570 IrlR Unknown Y  Y Y Y  
  PA4959 PA14_65540 FimX Unknown Phosphodiesterase (GGDEF and EAL domains). Signal transduction 
protein involved in twitching motility phosphotransfer activity, and 
cyclic di-GMP metabolism. Reduced in vitro cytotoxicity 
 (Huang et al. 2003; Kazmierczak et 
al. 2006; Kulasakara et al. 2006; Jain 
et al. 2012)  
PA4982 PA14_65860 PA4983 PA14_65880 AruS-AruR Arginine Antibodies against this protein found in CF patient sera.  Controls 
expression of the arginine transaminase (ATA) pathway.  
 Y (Beckmann et al. 2005; Yang & Lu 
2007)  
PA5124 PA14_67670 PA5125 PA14_67680 NtrB-NtrC PII – nitrogen 
status 
Responds to cellular nitrogen levels and activates nitrogen 
scavenging genes. 
 Y Y Y (Li & Lu 2007) 
PA5165 PA14_68230 PA5166 PA14_68250 DctB-DctD C4-
dicarboxylates 
Controls expression of C4-dicarboxylate transporters.  Y Y Y Y (Valentini et al. 2011) 
PA5199 PA14_68680 PA5200 PA14_68700 AmgS-
AmgR 
Aminoglycosides Aminoglycoside resistance and cell envelope stress response. 
Described as essential in PA14. 
 Y Y Y (Lau et al. 2013; Lau et al. 2015)  
  
PA5364 PA14_70790 Unknown  Y  
PA5484 PA14_72390 PA5483 PA14_72380 KinA-AlgB Unknown Alginate biosynthesis. Virulence, acute/chronic switch.   Y Y Y (Leech et al. 2008; Chand et al. 
2011; Chand et al. 2012)  
PA5512 PA14_72740 PA5511 PA14_72720 MifS-MifR α-Ketoglutarate Biofilm formation and metabolism.       Y  (Tatke et al. 2015) 
Table 1: The TCSs that have been implicated in P. aeruginosa virulence and/or antibiotic resistance. The TCSs known to form multikinase-networks are listed in the first section and the others are listed in the second section. The columns 
to the right of the description column refer to whole genome studies investigating virulence using the following methodologies: Tn-Seq, signature tagged mutagenesis, and the study of pathoadaptive mutations in CF patient isolates. “Y” 
indicates that the study has implicated the TCS in virulence. * highlights the five multikinase-networks that are discussed in depth in this minireview. 
Figure 1. The GacS network including the closely affiliated HptB and SagS/BfiS branches. Red 
ovals show SKs, blue ovals show RRs, the purple oval shows the HptB protein and the grey ovals 
show other proteins in the system. Arrows show stimulatory interactions, while blunt end lines show 
inhibitory interactions and bulb-ended lines show interactions that can be stimulatory or inhibitory 
depending on conditions. The primary output of the GacS side of the pathway is the small RNAs 
RsmY and RsmZ, which sequester the post-transcriptional regulators, RsmA and RsmN. When RsmA 
and RsmN are sequestered, virulence genes associated with chronic infection are upregulated while 
those associated with acute virulence genes are downregulated. Conversely, when RsmA and RsmN 
are free, the acute virulence genes are upregulated and the chronic infection genes are downregulated. 
The HptB and SagS/BfiS branches of the pathway also regulate RsmY and RsmZ levels, respectively. 
The role of HsbA differs depending on whether it is phosphorylated (blue arrow) or dephosphorylated 
(red arrow). Two diguanylate cyclases are controlled by this network, HsbD and SadC. 
Figure 2. Model of the Roc network (A) and Rcs/Pvr network (B). Red ovals indicate the SKs, 
while the blue ovals are the RRs. The green oval is the unknown component that regulates cupB 
fimbriae. Arrows specifies positive interactions and blunt ended lines show inhibitory interactions. 
The bulb ended line indicates that RcsC can have either stimulatory or inhibitory effects on RcsB 
depending on conditions.  
Figure 3. The network controlling the aminoarabinose modification of lipid A component of 
lipopolysaccharide. Five TCSs work together to sense magnesium ions, zinc ions and cationic 
antimicrobial peptides to regulate the expression of the arnBCADTEF operon which encodes the LPS 
modification enzymes. The LPS modification enhances resistance to host derived cationic 
antimicrobial peptides and to polymyxin antibiotics. 
Figure 4. The Wsp chemosensory pathway. The proteins involved in the pathway are a methyl-
accepting protein (WspA), CheW homologues (WspB and WspD), a CheA homologue (WspE), a 
diguanylate cyclase RR (WspR), a methylesterase RR (WspF) and a methyltransferase (WspC). 
Mechanical pressure associated with surface growth activates WspA, which promotes the 
autophosphorylation of WspE. WspE phosphorylates its two RRs, WspR and WspF. Phosphorylated 
WspR catalyses the synthesis of c-di-GMP (the secondary messenger output of this system). 
Meanwhile, phosphorylated WspF acts to reset the system by removing methyl groups from WspA, 
reducing its ability to activate WspE.  The methylesterase activity of WspF is opposed by the 
constitutive methyltransferase activity of WspC. 
Figure 5. The Chp/FimS/AlgR network controls the production and operation of the type 4 pili, 
involved in surface attachment and twitching motility, and the expression of virulence genes. 
Surface contact is detected by PilJ (an MCP homologue), it activates signalling by two SKs, ChpA (a 
CheA homologue) and FimS. FimS phosphorylates its RR, AlgR leading to the activation of its 
regulon (T4P genes, virulence genes, the diguanylate cyclase gene mucR, and pilY1). ChpA 
phosphorylates three RRs, ChpB (a CheB homologue that mediates adaptation), PilG which activates 
the adenylate cyclase (CyaB) and the pilus extension ATPase (PilB), and PilH which may activate the 
pilus retraction ATPases (PilT/U) and inhibit adenylate cyclase (CyaB). The cAMP produced by 
CyaB binds to and activates the transcription factor Vfr, leading to the activation of its vast regulon, 
which includes T4P genes, virulence genes, the fimS/algR TCS and pilY1. After prolonged surface 
contact, the number of T4P increases due to AlgR and Vfr activity, which promotes the secretion of 
the outer membrane surface associated PilY1 protein. PilY1 signals to the diguanylate cyclase, SadC, 
which produces c-di-GMP that leads to the upregulation of biofilm genes and the downregulation of 
the T4P. 





